nandrolone has been researched along with goserelin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isaka, K; Kato, R; Kojima, J; Nagamitsu, Y; Nishi, H; Sasaki, T; Takaesu, Y | 1 |
| Akira, S; Matsushima, T; Takeshita, T; Yoneyama, K | 1 |
| Lumbiganon, P; Pattanittum, P; Sangkomkamhang, US | 1 |
| Huang, Y; Ji, M; Jiao, X; Li, J; Li, Q; Wang, G; Yuan, M | 1 |
1 review(s) available for nandrolone and goserelin
| Article | Year |
|---|---|
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
Topics: Adult; Antineoplastic Agents, Hormonal; Bias; Contraceptives, Oral; Desogestrel; Female; Goserelin; Humans; Intrauterine Devices, Medicated; Leiomyoma; Leuprolide; Levonorgestrel; Lynestrenol; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Nandrolone; Norethindrone Acetate; Premenopause; Progestins; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Neoplasms | 2020 |
1 trial(s) available for nandrolone and goserelin
| Article | Year |
|---|---|
Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis.
Topics: Adult; Conservative Treatment; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Hormone Antagonists; Humans; Nandrolone; Pain; Postoperative Care; Prospective Studies; Recurrence; Secondary Prevention | 2016 |
2 other study(ies) available for nandrolone and goserelin
| Article | Year |
|---|---|
Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest.
Topics: Adenomyosis; Adult; Cohort Studies; Drug Administration Schedule; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Middle Aged; Nandrolone; Recurrence; Retrospective Studies; Treatment Outcome; Withholding Treatment | 2020 |
A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea.
Topics: Adenomyosis; Cohort Studies; Dysmenorrhea; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Nandrolone | 2022 |